or Try an Advanced Search...

    Pulmonary Disease Stocks List

    Symbol Grade Name % Change
    AMED A Amedisys Inc 0.00
    INVA A Innoviva, Inc. -0.79
    AZN B Astrazeneca PLC 1.60
    PULM C Pulmatrix, Inc. 0.93
    GTLS C Chart Industries, Inc. 1.31
    INGN C Inogen, Inc 0.76
    OPK C OPKO Health Inc. -0.70
    LUNG F Pulmonx Corporation -2.12
    DVAX F Dynavax Technologies Corporation -1.76
    APLS F Apellis Pharmaceuticals, Inc. 0.94
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Medical Devices Metal Fabrication
    Related Stock Lists: Chronic Obstructive Pulmonary Disease Medicine Asthma Autoimmune And Inflammatory Disease Cancer Inflammatory Diseases Pulmonology Alzheimer's Disease Biopharmaceutical Chronic Kidney Disease Clinical Medicine Drugs End Stage Renal Disease Heart Disease Industrial Gases Kidney Disease Medical Technology Organ Systems Oxygen Renal Disease

    Related ETFs - A few ETFs which own one or more of the above listed Pulmonary Disease stocks.

    Symbol Grade Name Weight
    IWV B iShares Russell 3000 ETF 8.0
    THNR C Amplify Weight Loss Drug & Treatment ETF 7.28
    ITOT B iShares Core S&P Total U.S. Stock Market ETF 7.0
    GERM B ETFMG Treatments Testing and Advancements ETF 6.33
    IWM B iShares Russell 2000 ETF 6.0
    View all Pulmonary Disease ETFs...
    Compare ETFs
    Compare GERM to IWM Compare ITOT to GERM Compare THNR to ITOT

        Pulmonary Disease Stocks Recent News

        Date Stock Title
        Aug 1 LUNG Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript
        Jul 31 INVA Innoviva: Q2 Earnings Snapshot
        Jul 31 LUNG Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates
        Jul 31 INVA Innoviva GAAP EPS of -$0.55, revenue of $99.9M
        Jul 31 LUNG Pulmonx GAAP EPS of -$0.39
        Jul 31 INVA Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
        Jul 31 LUNG Pulmonx Reports Second Quarter 2024 Financial Results
        Jul 31 APLS Apellis Pharmaceuticals Q2 2024 Earnings Preview
        Jul 31 GTLS IAC Gears Up to Report Q2 Earnings: Here's What to Expect
        Jul 30 GTLS Exploring Analyst Estimates for Chart Industries (GTLS) Q2 Earnings, Beyond Revenue and EPS
        Jul 30 APLS When Will Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Breakeven?
        Jul 30 AZN AstraZeneca reports positive data from chronic lymphocytic leukaemia therapy trial
        Jul 30 AZN NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu for NHS
        Jul 29 LUNG Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
        Jul 29 GTLS IDEX (IEX) to Report Q2 Earnings: What's in the Offing?
        Jul 29 INGN Inogen (NASDAQ:INGN) investors are sitting on a loss of 88% if they invested three years ago
        Jul 29 AZN Fixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial
        Jul 28 GTLS Should You Consider Adding Chart Industries (GTLS) to Your Portfolio?
        Jul 28 AZN AstraZeneca (LON:AZN) Has Announced A Dividend Of $0.776
        Jul 27 AZN AstraZeneca Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Medical Devices Metal Fabrication
        Related Stock Lists: Chronic Obstructive Pulmonary Disease Medicine Asthma Autoimmune And Inflammatory Disease Cancer Inflammatory Diseases Pulmonology Alzheimer's Disease Biopharmaceutical Chronic Kidney Disease Clinical Medicine Drugs End Stage Renal Disease Heart Disease Industrial Gases Kidney Disease Medical Technology Organ Systems Oxygen Renal Disease
        Pulmonary Disease

        Pulmonary disease is a broad term that refers to any disease or disorder that affects the lungs. This includes conditions such as asthma, COPD, pneumonia, and lung cancer. Pulmonary diseases can be caused by a variety of factors, including environmental pollutants, smoking, and genetics. Treatment for pulmonary diseases varies depending on the type and severity of the condition.

        Browse All Tags